Please select the option that best describes you:

Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients age 50-70 impact your adjuvant radiation recommendations?  

For example, would you feel comfortable offering APBI to an otherwise low risk patient in her 50s who did not have a SNB?